Table 1.
Patient characteristics at baseline visit for overall cohort, by study arm, study completion status and intervention adherence status
| Participant characteristic | All (n 118) | Study arm (%) | SCS (%) | Intervention adherence (%) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| S (n 41) | D (n 38) | C (n 39) | P | Complete (n 58) | Drop-out (n 21) | P | Adh (n 39) | Non-adh (n 19) | P | ||
| Age in years, mean (sd) | 56⋅6 (4⋅5) | 56⋅8 (4⋅4) | 56⋅8 (4⋅2) | 56⋅1 (4⋅9) | 0⋅69 | 56⋅8 (4⋅3) | 57⋅4 (4⋅3) | 0⋅794 | 56⋅6 (4⋅3) | 57⋅1 (4⋅4) | 0⋅721 |
| Ethnicity, n (%) | |||||||||||
| Chinese | 92 (78⋅0) | 31 (75⋅6) | 31 (81⋅6) | 30 (76⋅9) | 0⋅967 | 46 (79⋅3) | 16 (76⋅2) | 0⋅906 | 32 (82⋅1) | 14 (73⋅7) | 0⋅784 |
| Indian | 16 (13⋅6) | 6 (14⋅6) | 4 (10⋅5) | 6 (15⋅4) | 7 (12⋅1) | 3 (14⋅3) | 5 (12⋅8) | 2 (10⋅5) | |||
| Malay | 10 (8⋅5) | 4 (9⋅8) | 3 (7⋅9) | 3 (7⋅7) | 5 (8⋅6) | 2 (9⋅5) | 2 (5⋅1) | 3 (15⋅8) | |||
| Education, n (%) | |||||||||||
| Certification/Tertiary | 80 (67⋅8) | 26 (63⋅4) | 23 (60⋅5) | 31 (79⋅5) | 0⋅273 | 36 (62⋅1) | 13 (61⋅9) | 0⋅788 | 22 (56⋅4) | 14 (73⋅7) | 0⋅201 |
| Primary/Secondary | 34 (28⋅8) | 13 (31⋅7) | 13 (34⋅2) | 8 (20⋅5) | 20 (34⋅5) | 6 (28⋅6) | 16 (41⋅0) | 4 (21⋅1) | |||
| Monthly household income, n (%) | |||||||||||
| B40 (<RM 5000) | 42 (35⋅6) | 14 (34⋅1) | 14 (36⋅8) | 14 (35⋅9) | 0⋅991 | 22 (37⋅9) | 6 (28⋅6) | 0⋅841 | 17 (43⋅6) | 5 (26⋅3) | 0⋅634 |
| M40 (RM 5000–10 000) | 38 (32⋅2) | 14 (34⋅1) | 11 (28⋅9) | 13 (33⋅3) | 18 (31⋅0) | 7 (33⋅3) | 10 (25⋅6) | 8 (42⋅1) | |||
| T40 (RM 10 000–RM 50 000) | 33 (28⋅0) | 11 (26⋅8) | 10 (26⋅3) | 12 (30⋅8) | 15 (25⋅9) | 6 (28⋅6) | 10 (25⋅6) | 5 (26⋅3) | |||
| Age at menarche, median (sd) | 12⋅6 (1⋅3) | 12⋅5 (1⋅1) | 12⋅3 (1⋅3) | 12⋅8 (1⋅5) | 0⋅241 | 12⋅4 (1⋅1) | 12⋅6 (1⋅5) | 0⋅452 | 12⋅3 (1⋅1) | 12⋅4 (1⋅2) | 0⋅686 |
| Menopausal status, n (%) | |||||||||||
| Post-menopausal | 104 (88⋅1) | 35 (85⋅4) | 34 (89⋅5) | 35 (89⋅7) | 0⋅824 | 52 (89⋅7) | 17 (81⋅0) | 0⋅443 | 36 (92⋅3) | 16 (84⋅2) | 0⋅596 |
| Peri-menopausal | 14 (11⋅9) | 6 (14⋅6) | 4 (10⋅5) | 4 (10⋅3) | 6 (10⋅3) | 4 (19⋅0) | 3 (7⋅7) | 3 (15⋅8) | |||
| First FH of any cancer, n (%) | 52 (44⋅1) | 20 (48⋅8) | 16 (42⋅1) | 16 (41⋅0) | 0⋅694 | 28 (48⋅3) | 8 (38⋅1) | 0⋅449 | 20 (51⋅3) | 8 (42⋅1) | 0⋅537 |
| First FH of breast cancer, n (%) | 14 (11⋅9) | 5 (12⋅2) | 5 (13⋅2) | 4 (10⋅3) | 0⋅94 | 7 (12⋅1) | 3 (14⋅3) | 0⋅999 | 5 (12⋅8) | 2 (10⋅5) | 0⋅909 |
| Years since last mammogram, n (%) | |||||||||||
| Within 2 years | 36 (30⋅5) | 13 (31⋅7) | 13 (34⋅2) | 10 (25⋅6) | 0⋅564 | 21 (36⋅2) | 5 (23⋅8) | 0⋅516 | 16 (41⋅0) | 5 (26⋅3) | 0⋅304 |
| More than 2 years | 79 (66⋅9) | 27 (65⋅9) | 23 (60⋅5) | 29 (74⋅4) | 35 (60⋅3) | 15 (71⋅4) | 21 (53⋅8) | 14 (73⋅7) | |||
| Never | 3 (2⋅5) | 1 (2⋅4) | 2 (5⋅3) | 0 (0⋅0) | 2 (3⋅4) | 1 (4⋅8) | 2 (5⋅1) | 0 (0⋅0) | |||
SCS, study completion status; S, supplement arm; D; dietary arm; C, control arm; P, P-value calculated using a Fisher's Exact test; Adh, adherence; Non-adh, non-adherence; sd, standard deviation; RM, Ringgit Malaysia; FH, family history.